292 related articles for article (PubMed ID: 16380624)
1. Hyponatremia from oxcarbazepine and carbamazepine.
Dong X; Leppik IE; White J; Rarick J
Neurology; 2005 Dec; 65(12):1976-8. PubMed ID: 16380624
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
[TBL] [Abstract][Full Text] [Related]
4. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Berghuis B; van der Palen J; de Haan GJ; Lindhout D; Koeleman BPC; Sander JW;
Epilepsia; 2017 Jul; 58(7):1227-1233. PubMed ID: 28542738
[TBL] [Abstract][Full Text] [Related]
5. Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Berghuis B; Hulst J; Sonsma A; McCormack M; de Haan GJ; Sander JW; Lindhout D; Koeleman BPC
Epilepsia; 2021 Mar; 62(3):778-784. PubMed ID: 33576502
[TBL] [Abstract][Full Text] [Related]
6. Hyponatremia associated with repeated use of levetiracetam.
Nasrallah K; Silver B
Epilepsia; 2005 Jun; 46(6):972-3. PubMed ID: 15946344
[TBL] [Abstract][Full Text] [Related]
7. Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy.
Ortenzi A; Paggi A; Foschi N; Sabbatini D; Pistoli E
Funct Neurol; 2008; 23(2):97-100. PubMed ID: 18671911
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia.
Berghuis B; de Haan GJ; van den Broek MP; Sander JW; Lindhout D; Koeleman BP
Eur J Neurol; 2016 Sep; 23(9):1393-9. PubMed ID: 27333872
[TBL] [Abstract][Full Text] [Related]
9. Hyponatremic coma under oxcarbazepine therapy.
Steinhoff BJ; Stoll KD; Stodieck SR; Paulus W
Epilepsy Res; 1992 Mar; 11(1):67-70. PubMed ID: 1563340
[TBL] [Abstract][Full Text] [Related]
10. Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia.
Kim YS; Kim DW; Jung KH; Lee ST; Kang BS; Byun JI; Yeom JS; Chu K; Lee SK
Seizure; 2014 Mar; 23(3):208-12. PubMed ID: 24378204
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
12. Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients.
Intravooth T; Staack AM; Juerges K; Stockinger J; Steinhoff BJ
Epilepsy Res; 2018 Jul; 143():7-10. PubMed ID: 29631131
[TBL] [Abstract][Full Text] [Related]
13. Effects of oxcarbazepine on sodium concentration and water handling.
Sachdeo RC; Wasserstein A; Mesenbrink PJ; D'Souza J
Ann Neurol; 2002 May; 51(5):613-20. PubMed ID: 12112108
[TBL] [Abstract][Full Text] [Related]
14. [A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine].
Gumbrevicius G; Sveikata A
Medicina (Kaunas); 2006; 42(8):649-52. PubMed ID: 16963831
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study.
Yamamoto Y; Takahashi Y; Imai K; Ohta A; Kagawa Y; Inoue Y
Seizure; 2019 Dec; 73():26-30. PubMed ID: 31707295
[TBL] [Abstract][Full Text] [Related]
16. Oxcarbazepine-induced hyponatremia, a cross-sectional study.
Nielsen OA; Johannessen AC; Bardrum B
Epilepsy Res; 1988; 2(4):269-71. PubMed ID: 3197696
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.
Coppola G; Franzoni E; Verrotti A; Garone C; Sarajlija J; Operto FF; Pascotto A
Brain Dev; 2007 Jun; 29(5):281-4. PubMed ID: 17055681
[TBL] [Abstract][Full Text] [Related]
18. The regulation of serum sodium after replacing carbamazepine with oxcarbazepine.
Isojärvi JI; Huuskonen UE; Pakarinen AJ; Vuolteenaho O; Myllylä VV
Epilepsia; 2001 Jun; 42(6):741-5. PubMed ID: 11422328
[TBL] [Abstract][Full Text] [Related]
19. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
Schmidt D; Elger CE
Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
[TBL] [Abstract][Full Text] [Related]
20. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
